Ειδήσεις: ANALYST COVERAGE | PXAI

Version	Description	Date
8.42	[ADDED SOURCE REGISTRY LIST VIEW]	04/03/2026 16:19
8.41	[LOCALIZED INDEX.PHP MENU AND MODALS TO US ENGLISH]	04/03/2026 16:11
8.40	[TRANSLATED FRONTEND TO US ENGLISH]	04/03/2026 16:10
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:50
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:46
8.40	[REVERTED TO STANDARD TABLE LAYOUT (US ENGLISH)]	04/03/2026 15:40
8.39	[FIXED DB CONNECTION SCOPE IN SOURCES LOGIC]	04/03/2026 15:38
8.38	[TRANSLATED SOURCES VIEW TO US ENGLISH]	04/03/2026 15:01
8.37	[FULL FRONTEND TRANSLATION (MENU, FEED, COMMENTS, TTS) TO US ENGLISH.]	04/03/2026 14:58
8.67	[MANUAL OVERRIDE OF GREEK MENU ITEMS]	04/03/2026 13:36
8.66	[NGINX OPTIMIZED MENU FIX]	04/03/2026 13:33
8.65	[FIXED GREEK MENU ITEMS]	04/03/2026 13:32
8.60	[MENU & UI LOCALIZATION TO US ENGLISH]	04/03/2026 13:30
8.50	[FULL TRANSLATION TO US ENGLISH]	04/03/2026 13:27
9.75	[INJECTED EVENT FUSION_SUMMARY INTO FEED LOOPS TO DISPLAY AI TAGS CORRECTLY]	26/02/2026 14:44

25/03 09:24 defenseworld.net

Generate Biomedicines (NASDAQ:GENB) Coverage Initiated by Analysts at The Goldman Sachs Group

Generate Biomedicines Goldman Sachs Guggenheim Cantor Fitzgerald buy rating price target

25/03 09:08 defenseworld.net

CommVault Systems (NASDAQ:CVLT) Coverage Initiated by Analysts at Loop Capital

CommVault CVLT analyst coverage price target buy rating Truist

25/03 08:52 defenseworld.net

LiveRamp (NYSE:RAMP) Now Covered by Analysts at Evercore

LiveRamp NYSE:RAMP analyst coverage price target equity research Evercore

25/03 08:52 defenseworld.net

Nektar Therapeutics (NASDAQ:NKTR) Now Covered by Analysts at Wedbush

Nektar Therapeutics NKTR analyst coverage Wedbush HC Wainwright TD Cowen

25/03 08:06 defenseworld.net

Xencor’s (XNCR) “Neutral” Rating Reaffirmed at JPMorgan Chase & Co.

Xencor JPMorgan neutral rating price objective biopharma analyst coverage

24/03 19:04 defenseworld.net

ArriVent BioPharma (NASDAQ:AVBP) Price Target Raised to $45.00 at B. Riley Financial

ArriVent BioPharma AVBP price target B. Riley Financial analyst coverage biotech

24/03 18:35 defenseworld.net

Red Rock Resorts (NASDAQ:RRR) Coverage Initiated by Analysts at Benchmark

Red Rock Resorts NASDAQ:RRR analyst coverage price target buy rating bullish sentiment

20/03 08:56 defenseworld.net

4D Molecular Therapeutics’ (FDMT) Buy Rating Reaffirmed at Chardan Capital

4D Molecular Therapeutics FDMT buy rating price target analyst coverage

20/03 08:24 defenseworld.net

Aclaris Therapeutics’ (ACRS) “Buy” Rating Reaffirmed at HC Wainwright

Aclaris Therapeutics HC Wainwright buy rating sell rating biotech EPS forecast

20/03 08:24 defenseworld.net

Aclaris Therapeutics’ (ACRS) “Buy” Rating Reaffirmed at HC Wainwright

Aclaris Therapeutics HC Wainwright buy rating sell rating biotech EPS forecast

Loading...